Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 64% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors at 1 institution in 1 country.
Siva ThirugnanamTulane National Primate Research Center, Covington, LA 70433, USA.
Edith M WalkerTulane National Primate Research Center, Covington, LA 70433, USA.
Faith SchiroTulane National Primate Research Center, Covington, LA 70433, USA.
Pyone P AyeTulane National Primate Research Center, Covington, LA 70433, USA.
Jay RappaportTulane National Primate Research Center, Covington, LA 70433, USA.
Namita RoutTulane National Primate Research Center, Covington, LA 70433, USA.
Tulane University · US
Funding
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Viral Testing CoreU42OD024282 · OD · TULANE UNIVERSITY OF LOUISIANA · PI KASI E RUSSELL-LODRIGUE · 2017 to 2026
$25.7M
Viral Testing Core - Maintenance of an SPF Macaque Breeding Colony for AIDS ResearchU42OD010568 · OD · TULANE UNIVERSITY OF LOUISIANA · PI Eric J. Vallender · 2013 to 2026
$21.7M
Gamma Delta T cell and microbial modulation to target chronic SIV-associated inflammationR01DK131930 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI Namita Rout · 2022 to 2026
$3.6M
Genetically Modified Gamma Delta T Cells to Target SIV ReservoirsR33AI136100 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI ROUT, NAMITA · 2020 to 2022
$1.5M
High Throughput Multicolor Flow Cytometer Cell AnalyzerS10OD026800 · OD · TULANE UNIVERSITY OF LOUISIANA · PI KAUR, AMITINDER · 2019 to 2019
$594k
Innate immune mechanisms of epithelial barrier disruption during treated HIV and SIV infectionsR56DK131531 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI ROUT, NAMITA, WELSH, DAVID A · 2022 to 2022
$555k
Development of Gamma delta CAR-T cells to target CNS HIV reservoirR21MH132483 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI ROUT, NAMITA · 2023 to 2024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161 · full record | OpenQuestion